|
|
Volumn 96, Issue 18, 2004, Pages 1354-1355
|
|
For phase I studies, ethical and practical concerns abound
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER REGRESSION;
CANCER RESEARCH;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
COMPREHENSION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SCREENING;
DRUG WITHDRAWAL;
EXPERIMENTATION;
HUMAN;
HYPOTHESIS;
INFORMED CONSENT;
INTERPERSONAL COMMUNICATION;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL DECISION MAKING;
MEDICAL ETHICS;
MEDICAL SOCIETY;
METHODOLOGY;
MOTIVATION;
NOTE;
PATIENT CARE;
PATIENT REFERRAL;
PATIENT RIGHT;
PATIENT SELECTION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
RESEARCH ETHICS;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
SYMPOSIUM;
TREATMENT OUTCOME;
UNITED STATES;
ARTICLE;
DECISION MAKING;
ETHICS;
HUMAN EXPERIMENT;
PATIENT PARTICIPATION;
PSYCHOLOGICAL ASPECT;
RESEARCH SUBJECT;
UNCERTAINTY;
CHOICE BEHAVIOR;
CLINICAL TRIALS, PHASE I;
ETHICS, CLINICAL;
ETHICS, RESEARCH;
HUMAN EXPERIMENTATION;
HUMANS;
INFORMED CONSENT;
PATIENT PARTICIPATION;
RESEARCH SUBJECTS;
UNCERTAINTY;
|
|
EID: 4644327600
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/96.18.1354 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|